A study to observe the drugs used in women with heavy menstrual bleeding

Not Applicable

Completed

• Conditions: Health Condition 1: null- Dysfunctional uterine bleeding

• Registration Number: CTRI/2018/05/013791
• Lead Sponsor: Kempegowda institute of medical sciences and research hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2017-06-30
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 110

Inclusion Criteria

1. Subjects between 20-50 years of age diagnosed as dysfunctional uterine bleeding.

2.Willingness to give written informed consent and availability for regular follow up.

Exclusion Criteria

1. Subjects with pelvic pathologies such as uterine fibroids, endometriosis, endometrial polyps, PCOS and pelvic inflammatory disease.

2. Pregnant women or lactating women in the first 6 months of postnatal period, women who have had an abortion during the previous 3 months, IUCD or contraceptive pill users.

3. Presence of medical diseases like cardiac dysfunction, uncontrolled diabetes mellitus, uncontrolled hypertension, liver and renal dysfunction, migraine, thyroid disorders, cerebrovascular disease, past or present neoplastic diseases, thromboembolism and coagulation disorders.

4. Women on immunosuppressant therapy, anticoagulation therapy, or who have a known hypersensitivity to any of the drugs used in dysfunctional uterine bleeding.

5. Subjects who have participated in any clinical trial in the past 3 months.

Study & Design

• Study Type: Observational
• Study Design: Not specified